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Abstract. 
 
We have identiﬁed a pair of related yeast 
proteins, Sro7p and Sro77p, based on their ability to 
bind to the plasma membrane SNARE (SNARE) pro-
tein, Sec9p. These proteins show signiﬁcant similarity to 
the 
 
Drosophila
 
 tumor suppressor, 
 
lethal giant larvae
 
 
and to the neuronal syntaxin–binding protein, tomosyn. 
 
SRO7
 
 and 
 
SRO77
 
 have redundant functions as loss of 
both gene products leads to a severe cold-sensitive 
growth defect that correlates with a severe defect in 
exocytosis. We show that similar to Sec9, Sro7/77 func-
tions in the docking and fusion of post-Golgi vesicles 
with the plasma membrane. In contrast to a previous 
report, we see no defect in actin polarity under condi-
tions where we see a dramatic effect on secretion. This 
demonstrates that the primary function of Sro7/77, and 
likely all members of the 
 
lethal giant larvae
 
 family, is in 
exocytosis rather than in regulating the actin cytoskele-
ton. Analysis of the association of Sro7p and Sec9p 
demonstrates that Sro7p directly interacts with Sec9p 
both in the cytosol and in the plasma membrane and 
can associate with Sec9p in the context of a SNAP re-
ceptor complex. Genetic analysis suggests that Sro7 and 
Sec9 function together in a pathway downstream of the 
Rho3 GTPase. Taken together, our studies suggest that 
members of the 
 
lethal giant larvae
 
/tomosyn/Sro7 family 
play an important role in polarized exocytosis by regu-
lating SNARE function on the plasma membrane.
Key words: exocytosis • SNARE complex • cell po-
larity • tumor suppressor • tomosyn
 
Y
 
EAST
 
 cells grow asymmetrically by delivering pro-
teins and lipids to specific sites on the plasma mem-
brane. The site of exocytic delivery that corre-
sponds to a small region at the growing bud tip for much of
the cell cycle becomes delocalized within the bud as it en-
larges and, finally, relocalizes to the mother–bud junction
before cell division (Tkacz and Lampen, 1972, 1973; Field
and Schekman, 1980). This process requires a continual
coordination between the exocytic machinery and the ac-
tin cytoskeleton. In particular, the integrity and polarity of
the actin cytoskeleton (Novick and Botstein, 1985; Pruyne
et al., 1998) as well as the function of an unconventional
type V myosin, Myo2 (Lillie and Brown, 1994), have been
shown to be required for the recruitment of some of the
spatial landmarks for the targeting and fusion of post-
Golgi vesicles to specific sites on the plasma membrane
(TerBush et al., 1996; Ayscough et al., 1997; Finger et al.,
1998). In addition, the Rab GTPase Sec4 (Walch-Soli-
mena et al., 1997; Guo et al., 1999) that is required for
transport from the Golgi apparatus to the plasma mem-
brane in yeast was found to be functionally intertwined
with the Rho GTPase Rho3, previously identified for its
maintenance of actin polarity in yeast (Imai et al., 1996).
More recently, Rho3 has been suggested to have a direct
role in exocytosis. Two-hybrid analysis has suggested that
it has the capacity to interact with elements of the exocytic
machinery (Robinson et al., 1999), and we have shown a
direct involvement of Rho3 both in exocytic fusion and in
the polarized delivery of vesicles from the mother to the
bud (Adamo, J., G. Rossi, and P. Brennwald, manuscript
submitted for publication).
Once the post-Golgi vesicle has been delivered to the
target membrane, formation of a tightly packed complex
between the vesicle SNAP receptor (SNARE)
 
1
 
 proteins
Snc1/2p (Protopopov et al., 1993) and the plasma mem-
brane SNARE proteins Sec9p (Brennwald et al., 1994)
and Sso1/2p (Aalto et al., 1993) finally determines a late
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1.
 
 Abbreviations used in this paper:
 
 CPY, carboxypeptidase Y; CT, car-
boxy terminal; DAPI, 4
 
9
 
,6-diamidino-2-phenylindole; DSP, dithiosuccin-
nimidylpropionate; GST, glutathione-S-transferase; PIC, protease inhibi-
tor cocktail; Q-SNARE, glutamine-containing SNARE; SNARE, SNAP
receptor; TEAE, triethanolamine-EDTA; t-SNARE, target SNARE;
VAMP, vesicle-associated membrane protein; YPD, yeast extract/pep-
tone/glucose. 
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event in the fusion of the vesicle with the target mem-
brane. The SNARE complex structure is composed of four
helical domains whose COOH termini must converge to
bring about membrane fusion (Katz et al., 1998). The
SNARE proteins have been structurally reclassified
into arginine-containing and glutamine-containing (Q-)
SNAREs and fusion competent SNARE complexes gen-
erally consist of four helix bundles of three Q-SNAREs to
one arginine-containing SNARE (Fasshauer et al., 1998).
Since the post-Golgi Q-SNAREs (Sec9p and Sso1/2p) in
yeast are evenly distributed around the perimeter of the
cell (Brennwald et al., 1994), additional modulators of such
proteins are required to activate the target Q-SNAREs at
the site of polarized exocytosis.
One such protein was identified recently in neurons,
named tomosyn (Fujita et al., 1998). Tomosyn is part of a
larger family including the yeast proteins Sro7 and Sro77
(Kagami et al., 1998) and the 
 
Drosophila
 
 tumor suppres-
sor, 
 
lethal giant larvae
 
 (Mechler et al., 1985). These pro-
teins have also been implicated in cytoskeletal functions.
The lethal giant larvae protein was shown to be physically
associated with the nonmuscle myosin II and cofraction-
ates with cytoskeletal components (Strand et al., 1994a).
 
SRO7
 
 was identified as a high copy suppressor of 
 
rho3
 
D
 
and has been shown to have strong genetic interactions
with two yeast myosins, Myo1 and Myo2 (Kagami et al.,
1998). Tomosyn was identified based on its ability to bind
syntaxin and appears to act as a modulator of neuronal
SNARE function by relieving the Q-SNARE syntaxin of
its inhibitor Sec1 (Fujita et al., 1998).
In this paper, we describe the identification and charac-
terization of the role of Sro7 and Sro77 in post-Golgi
transport in yeast. We find that these proteins bind to the
target SNARE (t-SNARE) Sec9p in vivo and in vitro, and
that like Sec9, loss of their function results in a pro-
nounced defect in Golgi-to-cell surface transport. We pos-
tulate that like its neuronal homologue tomosyn, Sro7 may
act to regulate SNARE assembly on the plasma mem-
brane, and that by acting downstream of Rho3 it may con-
tribute to the polarity of this process.
 
Materials and Methods
 
Media and Reagents
 
All strains were grown either in YP medium (1% bacto-yeast extract and
2% bacto-peptone; Difco Laboratories Inc.) with 2% glucose or in S mini-
mal media (0.67% yeast nitrogen base; Difco Laboratories Inc.) with 2%
glucose supplemented with the required amino acid. For whole cell label-
ing, strains were cultured in S minimal media with 2% glucose and without
methionine. The absorbance of cell suspensions was measured at 599 nm
in an Ultrospec Plus UV/visible spectrophotometer (Pharmacia). Sorbi-
tol, sodium azide, 
 
N
 
-ethylmaleimide, 
 
b
 
-mercaptoethanol, 
 
O
 
-dianasidine,
glucose oxidase, peroxidase, Triton X-100, TRITC-phalloidin, 4
 
9
 
,6-diami-
dino-2-phenylindole (DAPI), imidazole GDP, acid molybdate, Fiske-
Soubbarow reducer, cytochrome 
 
c
 
 oxidase, rotenone, NADPH polylysine,
and protease inhibitors were obtained from Sigma Chemical Co. Cacody-
late, glutaraldehyde, osmium oxide, uranyl acetate, Spurr resin, and 37%
formaldehyde were obtained from EM Sciences. [
 
35
 
S]Methionine, 
 
35
 
S-
Express label (a mixture of [
 
35
 
S]methionine and [
 
35
 
S]cysteine), and
 
125
 
I–protein A were purchased from NEN Life Science Products Inc.
Protein A–Sepharose CL-4B was purchased from Pharmacia Biotech.
Rhodamine-X–conjugated affinity-purified goat 
 
a
 
-rabbit IgG was pur-
chased from Jackson ImmunoResearch Laboratories. Molecular weight
markers and Tween 20 were obtained from Bio-Rad Laboratories.
 
Yeast Genetic Techniques
 
Yeast transformation was performed using the lithium acetate method
(Becker and Guarente, 1991) and transformants were selected on minimal
medium supplemented with the appropriate amino acid at 25
 
8
 
C. Crosses
of strains, sporulation of diploids, and tetrad dissections were performed
as described (Sherman et al., 1986).
 
Two-Hybrid Screening
 
The two-hybrid screening and assay protocols were similar to those de-
scribed previously (Durfee et al., 1993). 
 
SEC9
 
 and the COOH-terminal
SNAP-25–like domain of 
 
SEC9
 
 were amplified by PCR and inserted into
the 
 
GAL4
 
-binding domain vector, pAS1-CYH2. A yeast cDNA library,
prepared in the 
 
GAL4
 
 activation domain vector pACT, was coexpressed
with the 
 
GAL4BD
 
-
 
SEC9
 
 fusion vector in the yeast strain Y190. Interac-
tion of the 
 
GAL4
 
 
 
BD
 
 fusion and 
 
GAL4
 
 
 
AD
 
 fusion proteins allows for ex-
pression of the 
 
HIS3
 
 and lacZ reporter genes, thereby enabling cells to
grow in the absence of histidine and to exhibit 
 
b
 
-Gal activity. To assay
 
b
 
-Gal activity, a filter lift assay was used (Bartel et al., 1993). From 10
 
6
 
transformants, 250 clones could grow in the absence of histidine. 147 of
these clones exhibited 
 
b
 
-Gal activity. These clones were replated on 
 
1
 
His
plates and retested for 
 
b
 
-Gal activity. 77 clones exhibiting the strongest
 
b
 
-Gal activity were grown on plates containing both histidine and tryp-
tophan with 2.5 
 
m
 
g/ml cycloheximide. 63 clones lost 
 
b
 
-Gal activity after
treatment with cycloheximide. Plasmids from these clones were recovered
and reexamined for their ability to give rise to growth on 
 
2
 
His plates in
combination with the 
 
GAL4
 
 
 
BD
 
 fused to 
 
SEC9 
 
or the 
 
GAL4
 
 
 
BD
 
 fused to
a control construct. Two clones were found to give rise to growth on 
 
2
 
His
plates containing 50 mM 3-aminotriazol when in combination with the
 
GAL4
 
 
 
BD
 
 fused to 
 
SEC9 
 
construct but not with the 
 
GAL4
 
 
 
BD
 
 fused to
the control plasmid.
 
In Vitro Binding Reactions
 
The Sro7 sequence corresponding to its COOH-terminal 510 amino acids
and the Sro77 sequence corresponding to its COOH-terminal 521 amino
acids were placed under control of a T7 promoter in the pCITE-4c vector
(Novagen Inc.). The resulting plasmids were added to a reticulocyte ly-
sate–coupled in vitro transcription–translation system (TnT; Promega) in
the presence of [
 
35
 
S]methionine. For binding of the radiolabeled COOH-
terminal domains of Sro7 and Sro77 to glutathione-Sepharose–bound fu-
sion proteins, the [
 
35
 
S]methionine-labeled in vitro transcription–transla-
tion reaction mixture was preincubated with glutathione–Sepharose for 30
min on ice followed by centrifugation. The resulting supernatant was used
for binding reactions with glutathione-S-transferase (GST) fusion proteins
bound to glutathione-Sepharose as described previously (Rossi et al.,
1997). The recombinant GST-Sec9p fusion contained the NH
 
2
 
-terminal
150 residues of 
 
SEC9
 
 fused in frame to the synthetic 
 
SEC9
 
 SNAP-25 do-
main described previously (Rossi et al., 1997). This protein corresponds to
the minimal fully functional form of the protein.
 
Construction of Deletion Strains
 
The 
 
SRO7
 
 disruption construct was created by subcloning 750 bp immedi-
ately upstream and 770 bp immediately downstream of the 
 
SRO7 
 
ORF
(YPR032w) into the 
 
LEU2
 
 integration vector pRS305. The vector was lin-
earized and transformed into the yeast strain BY24 (
 
MAT a/
 
a
 
, 
 
ura3-52/
ura3-52
 
; 
 
leu2-3,112/leu2-3,112
 
; 
 
his3-
 
D
 
200/his3-
 
D
 
200
 
). Transformants were
sporulated and subjected to meiotic analysis. Tetrads exhibited a 2:2 seg-
regation pattern for leucine prototrophy but showed no defect in growth
at any temperature. The 
 
SRO77
 
 disruption construct was prepared by
subcloning 560 bp upstream and 860 bp immediately downstream of the
 
SRO77
 
 ORF (YBL106c) into the 
 
URA3
 
 integration vector pRS306. The
vector was linearized and transformed into the yeast strain BY24. Trans-
formants were sporulated and subjected to meiotic analysis. Tetrads ex-
hibited a 2:2 segregation pattern for uracil prototrophy and showed no de-
fect in growth at any temperature. The 
 
sro7
 
D
 
, 
 
sro77
 
D
 
 
 
double-disruptant
strain was created by crossing the 
 
sro7
 
D
 
 
 
disruptant strain with the 
 
sro77
 
D
 
disruptant strain. Diploids selected on 
 
2
 
leu,
 
2
 
ura media were sporulated
and subjected to meiotic analysis. The 
 
RHO3
 
 disruption construct was
created by subcloning 1,031 bp immediately upstream and 941 bp immedi-
ately downstream of the 
 
RHO3
 
 ORF into the 
 
LEU2
 
 integration vector
pRS305. The vector was linearized between the two flanking DNA frag-
ments and transformed into the yeast strain BY23 (
 
MAT a/
 
a
 
, ura3-52/
ura3-52, leu2-3,112/leu2-3,112
 
). Disruption was confirmed by PCR analy- 
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sis on genomic DNA from two independent transformants. Transformants
were sporulated and subjected to meiotic analysis.
 
Secretion Assays
 
Invertase assays were performed on several tetratype tetrads resulting
from a cross between the 
 
sro7
 
D
 
 
 
and 
 
sro77
 
D
 
 
 
single-disruptant strains. Cul-
tures were grown overnight to mid-log phase in YP with 2% glucose
(YPD) medium at the permissive temperature of 37
 
8
 
C. Strains were simul-
taneously shifted to 0.1% glucose media and to the restrictive temperature
of 19
 
8
 
C for 3 h. Internal and external invertase activity was measured at
the beginning and end of the shift as described previously (Nair et al.,
1990). The percentage of total invertase secretion was calculated by the
following formula: percent secretion 
 
5 D
 
external/(
 
D
 
internal 
 
1 D
 
exter-
nal). For analysis of the glycosylation state of invertase and carboxypepti-
dase (CPY), cells were grown overnight to mid-log phase at 37
 
8
 
C in YPD.
The strains were shifted to YP medium containing 0.1% glucose and incu-
bated at 19
 
8
 
C for an additional 3 h. The control strains 
 
sec18-1
 
 and 
 
sec4-8
 
strains were grown in YPD at 25
 
8
 
C to mid-log phase and shifted to 37
 
8
 
C
for 2 h. The strains were transferred to YP medium containing 0.1% glu-
cose and incubated at 37
 
8
 
C for an additional 3 h. Whole cell glass bead ly-
sates were prepared. Samples were subjected to 12.5% SDS-PAGE, trans-
ferred to nitrocellulose, and probed with affinity-purified polyclonal
 
a
 
-invertase antibody or polyclonal 
 
a
 
-CPY antibody followed by 
 
125
 
I–pro-
tein A as secondary.
 
Electron Microscopy
 
Transmission electron microscopy was performed essentially as described
previously (Walworth et al., 1992). Wild-type and 
 
sro7
 
D
 
, 
 
sro77
 
D
 
 
 
double
disruptions were grown overnight in YPD to early log at the permissive
temperature of 37
 
8
 
C. Cells were incubated in YP with 0.1% glucose at
19
 
8
 
C for 3 h. Approximately 10 OD
 
599 
 
units were filtered onto a 0.45-
 
m
 
m
nitrocellulose filter (Nalgene), washed once with 0.1 M cacodylate buffer,
pH 6.8, resuspended in 0.1 M cacodylate buffer with 3% glutaraldehyde,
incubated for 1 h at 25
 
8
 
C, and then overnight at 4
 
8
 
C. Samples were washed
one time with 5 ml of 50 mM potassium phosphate, pH 7.5, and sphero-
plasted in 1 ml of KPi with 0.3 mg/ml Zymolyase 100T for every 1 OD
 
599
 
unit of cells for 40 min at 37
 
8
 
C. Spheroplasts were pelleted and washed
two times with 1 ml of ice-cold cacodylate buffer and incubated with 2%
osmium tetraoxide (diluted in cacodylate buffer) for 1 h on ice in a hood.
The cell pellet was rinsed three times with water and incubated with 1.5 ml
of 2% uranyl acetate at 25
 
8
 
C for 1 h. Samples were dehydrated with 5-min
successive washes of 50, 70, 90, and 100% ethanol. After a final wash with
100% acetone, the samples were incubated with 50% acetone/50%
SPURR medium for 3 h before incubating with the final 100% SPURR
solution overnight at room temperature. After baking for 48 h at 80
 
8
 
C,
samples were sectioned and layered onto an uncoated copper grid and
poststained with lead citrate and uranyl acetate before viewing. Cells were
viewed on a JEOL 100CXII electron microscope.
 
Fluorescence Microscopy and Imaging
 
For actin staining, cells were grown to mid-log in YPD media and either
shifted to the restrictive temperature of 19
 
8
 
C for 3 h or kept at the permis-
sive temperature before fixation. Formaldehyde was added to 3.7% di-
rectly to the media and incubated for 10 min at room temperature and
centrifuged for 5 min at 3,000 
 
g
 
. A second round of fixation was per-
formed by resuspending the cell pellet in with 3.7% formaldehyde/0.1 M
KPO4 buffer, pH 6.5, incubated for 30 min at room temperature, and then
pelleted as above. The cell pellets were transferred to a sorbitol buffer
(1.2 M sorbitol, 0.1 M KPO4, pH 7.5) for overnight storage at 48C. The
next day, cells were permeabilized for 10 min in 0.1% Triton X-100 and
washed two times with PBS. Cells were resuspended in 100 ml of PBS and
stained in the dark for 25 min with 35 ml of 3.3 mM TRITC-phalloidin dis-
solved in methanol. Cells were washed six times with PBS, and then resus-
pended in the appropriate volume of mounting media (90% glycerol with
DAPI to visualize DNA and O-phenylenediamine to retard photobleach-
ing). Stained cells was viewed on a Nikon Eclipse Z600 microscope, im-
ages were captured with a Princeton Instruments CCD camera and Meta-
morph imaging software. 
For immunofluorescence staining with affinity-purified a-Sro7 antibod-
ies, yeast strains containing high copy vector only (pB23) or high copy
SRO7 (pB497) were grown overnight in selective media to early log
phase. 0.1 vol of 1 M KPO4 buffer, pH 6.5, and 0.1 vol of 37% formalde-
hyde were added directly to the media and incubated for 30 min at room
temperature. Cells were centrifuged for 5 min at 3,000 g. A second round
of fixation was performed by resuspending the cell pellet in with 3.7%
formaldehyde/0.1 M KPO4 buffer, pH 6.5, incubated for 90 min at room
temperature, and then pelleted as above. The cell pellets were transferred
to a sorbitol buffer (1.2 M sorbitol, 0.1 M KPO4, pH 7.5) for overnight
storage at 48C. Fixed cells were processed for immunofluorescence after
permeabilization with 0.5% SDS as described (Redding et al., 1991). Af-
finity-purified rabbit a-Sro7 was used at a 1:900 dilution. The Sro7 anti-
body was incubated for 30 min at 258C with permeabilized cells from a
strain containing the sro7 disruption before use. Rhodamine-X–conju-
gated affinity-purified goat a–rabbit IgG (Jackson ImmunoResearch Lab-
oratories, Inc.) was used at a 1:50 dilution. Stained cells were viewed on a
Zeiss LSM 510 confocal microscope and the images captured with LSM
510 software.
Antisera Production and Purification
Rabbit antisera was raised to the carboxy terminus of Sro7 by generating a
GST fusion protein with the COOH-terminal 219–amino acids of the Sro7
open reading frame. IgG was first purified from the crude rabbit serum on
a DEAE–AffiGel blue column (Bio-Rad Laboratories) according to the
manufacturer’s directions. The IgG fraction was affinity-purified by bind-
ing to the GST-Sro7 fusion protein that had been chemically cross-linked
to glutathione–Sepharose beads (Lane and Harlow, 1988), and then
eluted with 0.2 M glycine, pH 2.8. The peak of IgG was collected, dialyzed
against TS buffer (10 mM Tris, pH 7.5, 150 mM NaCl), and then absorbed
with GST protein that had been cross-linked to glutathione–Sepharose.
The remaining IgG was dialyzed against 50% glycerol (vol/vol) in 13 PBS
buffer and stored at –208C. The concentration of IgG was determined by
absorbance at 280 nm and confirmed by SDS-PAGE and Coomassie
staining. Affinity-purified antibodies to Sec9p, Sso1/2p, and Snc1/2p were
prepared in a similar fashion. Analysis of the a-Sso1/2p and a-Snc1/2 anti-
bodies has demonstrated that they each react well against both isoforms of
their respective duplicated gene families. Preimmune IgG for each rabbit
was purified on protein A–agarose columns, dialyzed into 50% glycerol/
PBS, and quantitated by absorbance at 280 nm.
Subcellular Fractionation
Cells containing vector only (pB23) or SRO7 on high copy (pB497) were
grown overnight in selective media, harvested, and grown in rich media
for 2 h. Approximately 108 OD599 were washed with 10 mM Tris, pH 7.5,
plus 10 mM azide and spheroplasted in 7.2 ml of spheroplast buffer (0.1 M
Tris, 10 mM azide, 1.2 M sorbitol, and 21 mM b-mercaptoethanol with 0.1
mg/ml Zymolyase 100T) for 30 min at 378C. The spheroplasts were lysed
in 3 ml of ice-cold triethanolamide-EDTA (TEAE)/sorbitol (10 mM
TEA, 1 mM EDTA, pH 7.2, and 0.8 M sorbitol) with 13 protease inhibi-
tor cocktail (protease inhibitor cocktail [PIC], 2 mM 4-(2-aminoethyl)
benzenesulfonyl fluoride, 0.5 mM PMSF, 20 mM pepstatin A, and 1 mg/ml
each of leupeptin, antipain, and aprotinin) and spun at 450 g for 3 min in a
cold centrifuge to get rid of unbroken cells. The lysate was divided into
two aliquots and diluted 1:1 with TEAE/sorbitol or TEAE/sorbitol/2%
Triton X-100. The lysates were spun at 30,000 g for 15 min in a Sorvall and
the supernatant and pellet fraction separated. The supernatant was ultra-
centrifuged at 100,000 g for 1 h at 48C. All pellets were normalized to the
volume of the supernatant fractions. Samples were boiled in SDS sample
buffer, run on a 7% or 12.5% SDS–polyacrylamide gel, and blotted with
affinity-purified a-Sro7p antibody (1:200) and polyclonal a-Sso1/2p anti-
body (1:1,000), respectively. All gels were put on the PhosphorImager
screen and radiolabeled bands were quantitated with the STORM using
ImageQuant software (both from Molecular Dynamics).
Sucrose Gradient Fractionation
Wild-type cells were grown in rich media, harvested, washed with 10 mM
Tris, pH 7.5, plus 10 mM azide and converted to spheroplasts as described
above. Spheroplasts prepared from z300 OD599 units of cells were resus-
pended in 6 ml of ice-cold TEAE/sorbitol (see above) and spun at 450 g
for 3 min at 48C to pellet unbroken cells. The cell-free lysate was spun at
36,000 g for 10 min and the supernatant fraction discarded. The pellet
fraction containing most of the cell membranes was resuspended in 2 ml of
ice-cold 15% sucrose (wt/wt) in TEA and 1 ml corresponding to z100
OD599 units was loaded on a sucrose gradient as described (Brennwald et
al., 1994). Enzyme assays were carried out as previously described (Wal-
worth and Novick, 1987). The GDPase activity is expressed as nanomoles
of liberated phosphate/fraction/minute. The cytochrome c reductase is ex-The Journal of Cell Biology, Volume 146, 1999 128
pressed as the rate of increase of the A550 of the reaction using 25 ml of
each fraction. Sro7p and the plasma membrane t-SNARE Sso1/2p were
detected by immunoblotting. All gels were put on the PhosphorImager
screen and radiolabeled bands were quantitated as described above.
DSP Cross-linking and Coimmunoprecipitation
Strains containing high copy myc-tagged SEC9 (pB37) and either full-
length SRO7 or SRO7-CT Sro7 in a CEN vector expressed under the reg-
ulation of the inducible GAL1 promoter (pB363 and pB367) were grown
overnight in synthetic media with raffinose. The cells were shifted to syn-
thetic media with 2% galactose and grown for 1 h at 308C. Approximately
6 OD599 were labeled with [35S]methionine and cysteine in 3 ml for 1 h at
308C. Cross-linking and immunoprecipitation were carried out as de-
scribed (Brennwald et al., 1994). After the labeling, cells were washed in
Tris-azide, spheroplasted, and lysed in 300 ml of PBS with PIC. The lysate
from each strain was divided into two pools each of 100 ml and treated
with or without the chemical cross-linker dithiosuccinnimidylpropionate
(DSP). After boiling and dilution with immunoprecipitation buffer, the
samples were treated with mAb 9E10. The samples were subjected to a
second round of denaturing immunoprecipitations by resuspending the
beads from the first immunoprecipitation in reducing boiling buffer.
Second immunoprecipitations were carried out with mAb 9E10 and
pAb a-Sro7. Samples were boiled in sample buffer and loaded on a 7 and
10% gel. The gels were treated with stain, destain, dried, and exposed to
film. Immunoprecipitations on detergent extracts were done as follows:
wild-type yeast strains were grown to mid-log phase overnight in rich me-
dia at 258C. Cells corresponding to z200 OD599 were washed in ice-cold
10 mM Tris with 10 mM azide and spheroplasted in 13.3 ml of spheroplast
buffer (50 mM KPi, 1.2 M sorbitol, 21 mM b-mercaptoethanol with 0.1
mg/ml Zymolyase 100T) for 30 min at 378C. Cells were lysed in 6.6 ml of
ice-cold extraction buffer (20 mM Hepes-KOH, 150 mM KCl, 0.5% NP-
40) with PIC, left to equilibrate on ice for 5 min, and then spun in a cold
microfuge to pellet the insoluble material. The supernatant fractions were
pooled and used to set up six 1-ml immunoprecipitations on ice. Affinity-
purified antibodies to Sro7p, Sec9p, Snc1/2p, and Sso1/2p were added in
saturating amounts and equivalent amounts of preimmune sera purified
from each respective rabbit was used as a control immunoprecipitation.
After 1 h on ice, 60 ml of 1:1 protein A–Sepharose was added for 1 h at 48C
on a nutator. Samples were washed four times in extraction buffer and the
beads boiled in 100 ml of sample buffer. Samples were run on SDS–poly-
acrylamide gels and blotted onto nitrocellulose. Sro7p, Sec9p, Snc1/2p,
and Sso1/2p were detected by immunoblot analysis with the respective an-
tibodies. All gels were quantitated as described above.
Native Immunoprecipitations of Supernatant and
Pellet Fractions
Wild-type cells corresponding to z200 OD599 were washed in ice-cold
10 mM Tris, 10 mM azide, and spheroplasted in 13.3 ml of spheroplast
buffer (100 mM Tris, 10 mM azide, 1.2 M sorbitol, 21 mM b-mercaptoeth-
anol, and 0.1 mg/ml of Zymolyase 100T). Spheroplasts were lysed in 5 ml
of ice-cold TEAE/sorbitol (see above) with PIC and spun at 450 g for 3
min at 48C to get rid of unbroken cells. The lysate was spun at 36,000 g to
separate supernatant and pellet fractions, and the pellets were normalized
to the volume of the supernatants. Both fractions were treated with 53
extraction buffer (100 mM Hepes-KOH, 750 mM KCl, 2.5% NP-40) with
PIC to a final concentration of 13, equilibrated on ice for 15 min and spun
in a cold microfuge to pellet insoluble material. Native immunoprecipita-
tions with saturating amounts of affinity-purified a-Sec9p, a-Sro7p,
a-Sso1/2p, and a-Snc1/2p polyclonal antibodies and preimmune antibod-
ies were carried out and analyzed as described above.
Results
Identification of Sro7 and Sro77 as
Sec9-binding Proteins
Using a yeast two-hybrid system (Durfree et al., 1993) to
isolate proteins that interact with Sec9p, we identified two
distinct cDNAs that yielded a strong and specific interac-
tion (as measured by histidine prototrophy and b-galac-
tosidase activity) when present in reporter cells with the
GAL4-SEC9 fusion (Fields and Song, 1989). Sequence
analysis of one of the interacting cDNAs revealed that it
encoded the COOH-terminal half of a recently described
gene known as SRO7 (Kagami et al., 1998). The other
cDNA encoded an unrelated protein and will be described
elsewhere. The interaction of Sec9p with the correspond-
ing region of Sro7p was specific since it did not yield a pos-
itive interaction when present with the GAL4 DNA–bind-
ing domain alone or the GAL4 DNA–binding domain
fused to several control proteins. Likewise, Sec9p did not
yield a positive interaction with the GAL4 activation do-
main alone or the GAL4 activation domain fused with sev-
eral control proteins (data not shown).
To corroborate the two-hybrid interaction between Sec9
and Sro7, we in vitro translated the region of Sro7 identi-
fied above in a rabbit reticulocyte lysate and examined its
ability to interact with the immobilized GST-Sec9p fusion
construct (see Materials and Methods for details about re-
combinant Sec9p construct). This COOH-terminal region
of Sro7p specifically associated only with the GST-Sec9p
construct (Fig. 1 A, left). Furthermore, Sro7p did not in-
teract with GST alone, GST-Sso1p, or GST-Snc1p. Yeast
contain a second gene, previously designated as SRO77,
with 55% identity to SRO7 (Fig. 1 B), and has been shown
to have overlapping function with SRO7 (Kagami et al.,
1998). In a parallel experiment, we in vitro translated the
corresponding domain of Sro77p and examined its ability
to interact with GST fusion constructs. Sro77p associated
with the GST construct containing Sec9p, but not signifi-
cantly with GST-Sso1p and GST-Snc1p (Fig. 1 A, right).
Sro7 is predicted to encode a 110-kD protein containing
two b-transducin–like WD-40 repeats that are contained
in the NH2-terminal half of the protein (Neer et al., 1994).
Only the COOH-terminal half of SRO7 is present in the
original isolate, suggesting that the WD-40 repeats are not
required for Sec9p interaction. Sro7 and Sro77 are the
only yeast members of a family of related proteins first
identified in Drosophila by the tumor suppressor protein,
lethal giant larvae (Mechler et al., 1985). Like Sro7 and
Sro77, the metazoan lethal giant larvae proteins are of sim-
ilar size and contain two predicted WD-40 repeats in simi-
lar regions of the protein (Fig. 1 B). While the two regions
of highest conservation between the yeast and metazoan
proteins are centered around the two WD-40 repeats,
three regions of conservation are also found in the
COOH-terminal halves of both Sro7 and Sro77 (corre-
sponding to residues 549–576, 675–719, and 813–849 in the
SRO7 coding sequence).
Recently, a neuronal-specific protein named tomosyn
was identified as a syntaxin-binding protein that shows an
extensive similarity to both lethal giant larvae and Sro7/77
(Fig. 1 B). This group suggested that tomosyn may act as
an activator of SNARE formation in neuronal cells (Fujita
et al., 1998). However, neither Sro7 nor any of the other
members of this family, described to date, contain a
VAMP-like domain, demonstrating that this is not a con-
served feature of this family (Fig. 1 B).
Phenotypic Characterization of sro7D, sro77D mutants
To examine the effect of loss of Sro7 and Sro77 function in
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these genes individually in a diploid yeast strain. After
sporulation and tetrad dissection, there was no observable
effect on growth of the resulting haploid disruptants con-
taining either the sro7D or sro77D allele. However, when
sro7 disruptants were crossed with sro77 disruptants, a
pronounced growth defect was observed at 258C in hap-
loid segregants containing both null alleles. Therefore,
these genes represent a functionally redundant gene fam-
ily (Fig. 2 A). Growth of these strains at lower tempera-
tures, such as 14 or 198C (not shown), further enhances
this growth defect, whereas growth at 378C reduces the
growth defect, demonstrating that the sro7D and sro77D
double mutants have a severe cold-sensitive growth defect.
This conditional growth defect allowed us to assess di-
rectly Sro7 and Sro77 function in the yeast secretory path-
way. We examined the secretory capacity of sro7D, sro77D
double-disruptant cells after a shift from the permissive
temperature of 378C to the nonpermissive temperature of
198C. In particular, we determined the ability to secrete in-
vertase (Esmon et al., 1981), a protein that follows the
classical secretory pathway from the ER to the extracellu-
lar periplasmic space. We performed invertase secretion
assays on wild-type (SRO7, SRO77), each of the two sin-
gle-disruptants (sro7D) and (sro77D), and the double-dis-
ruptant (sro7D, sro77D) strains. After a 3-h shift to low
glucose media (to derepress expression of invertase) at
198C, the wild-type strain and each of the single disruption
strains secreted 88–98% of the total invertase produced in
this period. In contrast, the sro7D, sro77D double mutant
strain secreted only 53% of the total invertase produced
Figure 1. Identification of Sro7p
and Sro77p as Sec9p-binding
proteins. (A) Interaction of in
vitro translated COOH-terminal
domains of Sro7 and Sro77p
with Sec9p. The COOH-termi-
nal domain of Sro7p (left) iden-
tified in the two-hybrid screen
and the homologous region of
Sro77p were radiolabeled by
coupled transcription/transla-
tion in rabbit reticulocyte ly-
sates. In vitro translation reac-
tions were incubated with
various recombinant SNARE
proteins immobilized on GST
beads (each at z1  mM in the
binding reaction), washed, and
the bound material was ana-
lyzed by SDS-PAGE and auto-
radiography. The positions of
molecular mass markers (ex-
pressed in kD) are indicated on
the left of the gels. The bands
corresponding to primary trans-
lation products of Sro7-CTp and
Sro77-CTp are indicated by ar-
rows. The lower molecular mass
band presumably represents
breakdown products. (B) Align-
ment of Sro7p and Sro77p with
three lethal giant larvae family
members and tomosyn: mouse
LGL (MgCl-1, GenBank acces-
sion number D16141), human
LGL (Hugl, GenBank acces-
sion number X86371), and
Drosophila LGL (lg(2)l, Swiss
protein accession number
P08111) and tomosyn (acces-
sion number U92072). Each
rectangle is drawn proportional
to the length of each coding se-
quence. The positions of the
predicted WD-40 repeats and
the VAMP-like domain are indi-
cated. The arrows indicate the region in Sro7p recovered by two-hybrid and used for the in vitro binding assays. The BLAST analysis
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during the shift, with the remaining 47% being intracellu-
lar (Fig. 3 A). These results demonstrate a clear defect in
the secretory pathway in response to loss of both Sro7 and
Sro77.
To determine the stage of the secretory pathway that
was blocked in the sro7D, sro77D cells, we examined the
glycosylation state of invertase and the vacuolar enzyme
CPY (Valls et al., 1987) after the temperature shift de-
scribed above. Whole cell lysates (including the secreted
periplasmic fraction) were prepared from each of the sro
mutant strains and subjected to SDS-PAGE and immu-
noblot analysis. As a control for defects in ER-to-Golgi
and post-Golgi transport, lysates from sec18-1 and sec4-8
(Novick et al., 1980) strains were prepared after a 2-h shift
to 378C. The results, shown in Fig. 3 B, demonstrate that
under conditions in which nearly half of the invertase is ac-
cumulated internally in sro7D, sro77D cells, virtually all of
the invertase is present in the fully glycosylated state. This
is similar to that seen with sec4-8, a late sec mutant
blocked in Golgi-to-cell surface transport (Fig. 3 B). In
contrast, the sec18-1 mutant shows a dramatic accumula-
tion of core-glycosylated invertase, indicative of a block in
ER-to-Golgi transport. To confirm that the secretory de-
fect observed in the sro7D, sro77D cells is at a post-Golgi
step, we examined the maturation of CPY in these strains.
CPY is a vacuolar enzyme that follows the same secretory
pathway as invertase until a late Golgi compartment,
where it is sorted away from secreted proteins into a dis-
tinct pathway that brings it to the vacuole to be cleaved
into its mature form (Valls et al., 1987). A diagnostic fea-
ture of post-Golgi–specific secretory mutants is the lack of
an effect on CPY transport. The results, shown in Fig. 3 B,
demonstrate that, as expected, the ER-blocked, core-gly-
cosylated (p1) form of CPY is the major form present in a
sec18-1 strain. However, only mature CPY (mCPY) is de-
tected in both the sec4-8 and the sro7D, sro77D mutants as
well as the single mutants and wild-type strains. Therefore,
the pronounced secretion defect observed in the sro7D,
sro77D mutant strain appears to be primarily a post-
Golgi–specific defect.
Another feature common to all known mutants blocked
in Golgi-to-cell surface transport in yeast is the accumula-
tion of 80–100 nm secretory vesicles (Novick et al., 1980).
To examine the morphological effects of loss of Sro7 and
Sro77, we performed thin section electron microscopy
(Walworth et al., 1992) on the double-disruptant strain fol-
lowing the same cold temperature shift protocol used in
the invertase secretion assays. Representative mutant and
wild-type cells are shown in Fig. 4 A. While the mutant
cells generally appeared somewhat larger on average than
Figure 2. SRO7 and SRO77 form a functionally
redundant gene family and the sro7D, sro77D mu-
tant exhibits a severe cold-sensitive phenotype.
(A) Tetrad dissection of a cross between sro7D
and sro77D single disruptants. Tetrads were dis-
sected and grown on YPD plates at 258C. Pin-
point colonies correspond to haploid segregants
containing disruptions of both SRO7 and SRO77.
Large colonies correspond to haploid segregants
containing wild-type copies of both SRO7 and
SRO77 or individual disruptions in either gene. T
refers to a tetratype and NPD refers to nonparen-
tal ditype segregation patterns observed after
scoring for auxotrophic markers for each disrup-
tion. (B) Cold sensitivity of the sro7D,  sro77D
double-disruptant strain. Each strain of a tet-
ratype tetrad was struck out onto YPD plates and
grown at either 37, 25, or 148C. The genotype of
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the wild-type cells, the most striking feature was that virtu-
ally all of the budded cells observed in the sro7D, sro77D
mutant strain showed a dramatic accumulation of 80–100 nm
vesicles. Furthermore, in most of the budded cells the vesi-
cles appeared to be significantly more abundant in the bud
than in the mother cell as is the case with most of the late
sec mutants (Walch-Solimena et al., 1997). As expected,
because of the normally rapid rate of exocytosis in yeast,
vesicles were quite rare in wild-type (SRO7, SRO77) cells
analyzed in parallel with the mutant strain.
sro7D, sro77D Mutants Do Not Exhibit Defects in
Actin Polarity
Previously, Kagami et al. (1998) reported defects in the
polarity and integrity of the actin cytoskeleton in sro7D,
Figure 3. The sro7D, sro77D mutant has a pronounced defect in Golgi-to-cell surface transport. (A) Invertase secretion is deficient in
the sro7D, sro77D mutant strain. Invertase secretion assays were performed after a temperature shift on several tetratype tetrads and a
representative example is shown. The left frame shows a comparison of the percentage of invertase secreted into the periplasm after a
3-h shift to the restrictive temperature (198C). The right frame shows the partitioning of invertase activity in the internal (intracellular)
and external (periplasmic) fractions of these cells. All samples were measured in duplicate and the SD determined from two separate
experiments. (B) The invertase that accumulates in sro7D, sro77D cells is fully glycosylated and transport of CPY to the vacuole is unaf-
fected. Wild-type, single-disruptant, and double-disruptant strains, in addition to sec4-8 and sec18-1 strains, were grown and shifted as in
A, except that sec4-8 and sec18-1 strains were grown for 2 h at 378C before lysis. Equivalent amounts of each strain were lysed with glass
beads, boiled in SDS sample buffer, subjected to SDS-PAGE, transferred to nitrocellulose, and probed with antibodies raised against
invertase (top) or CPY (bottom). Mutants that block secretion after exit from the Golgi apparatus, such as sec4-8, accumulate internal
pools of fully glycosylated invertase, whereas mutants that block at earlier stages, such as sec18-1, accumulate the core-glycosylated or
ER-modified form of invertase. Likewise post-Golgi sec mutants do not affect CPY transport and maturation (and therefore show only
the mature, mCPY form), unlike mutants that block earlier in the pathway such as sec18-1, which accumulates the core-glycosylated, p1
form of CPY. The forms of invertase and CPY found in the sro7D, sro77D cells suggest it is primarily affecting Golgi-to-cell surface
transport.The Journal of Cell Biology, Volume 146, 1999 132
sro77D mutants after an 18-h shift to 198C. However, we
observed pronounced secretory defects and accumulation
of secretory vesicles after only 3 h at 198C. Therefore,
we examined the status of the actin cytoskeleton by
rhodamine-phalloidin staining after a 3-h shift from 37 to
198C. The results, shown in Fig. 4 B, demonstrate that both
the polarized distribution of the cortical actin patches and
the integrity of the actin cables are normal in the sro7D,
sro77D mutant. Therefore, the secretory defect appears to
be the primary phenotype in this mutant and the cytoskel-
etal defects are likely to result from the loss of vesicular
transport to the cell surface.
Subcellular Localization of Sro7
Since Sro7p/77p both bind to Sec9p and function at the
same stage of exocytosis, we reasoned that the localization
of these proteins within the cell might overlap with that of
Sec9p. To examine the Sro7 protein function within yeast
cells and determine its subcellular localization, we raised
antibodies to the COOH-terminal 219 residues of the pro-
tein (see Materials and Methods). The affinity-purified an-
tibodies recognize a protein of z105 kD that corresponds
to the Sro7 protein, as it is absent in a strain that lacks
Sro7 and is greatly enhanced in cells carrying a plasmid
overexpressing the Sro7 protein (Fig. 5 A).
Fractionation (Fig. 5 B) of cells carrying Sro7 on single
copy (pB23) or on a high copy expression plasmid (pB497)
showed that z14% of Sro7 pellets were at a 30,000 g spin,
whereas z23% pellets were at 100,000 g. The 30,000 g pel-
let is presumably due to Sro7 association with a membrane
fraction as it is affected by the addition of 1% Triton X-100
to the cell lysate. The 100,000 g pellet is probably not a
membrane-associated fraction, as it is unperturbed by the
addition of detergent. This fraction could be either a large
complex of Sro7 in the cell or could be Sro7p that is associ-
ating with the cytoskeleton. Treatment with 1 M NaCl and
100 mM sodium bicarbonate also solubilized the protein
indicating that Sro7 is a peripheral membrane protein, al-
though the stability of the protein largely diminished un-
der these conditions (data not shown).
To determine the subcellular compartment with which
Figure 4. (A) Loss of Sro7 and Sro77
leads to the accumulation of a large
number of post-Golgi secretory vesi-
cles at the nonpermissive temperature.
The wild-type (SRO7, SRO77) and
double-disruptant (sro7D, sro77D)
strains were grown to mid-log phase at
378C, shifted to the restrictive tempera-
ture of 198C for 3 h, and then processed
for thin section electron microscopy.
High magnification micrographs of the
accumulated vesicles demonstrated
that  .90% of the vesicles had diame-
ters between 80 and 100 nm, identical
to that reported for other post-Golgi
sec mutants (Novick et al., 1980). (B)
Actin localization in wild-type (SRO7,
SRO77) and double-disruptant (sro7D,
sro77D) strains. Haploid cells were
grown overnight at the permissive tem-
perature of 378C to log phase, and then
shifted to the restrictive temperature of
198C for 3 h before fixing, permeabiliz-
ing, and staining with TRITC-phalloi-
din. Bars: A, 1 mm; B, 5 mm.Lehman et al. Yeast Tomosyn Homologues Function in Exocytosis 133
Sro7 is associated, fractionation was performed by velocity
sedimentation through sucrose gradients (Fig. 6 A). A ly-
sate from a wild-type strain was layered directly onto a 20–
55% sucrose gradient. After centrifugation, the positions
of various membrane compartments within the gradient
were determined by enzymatic assays or by quantitative
immunoblotting of marker proteins. Sro7 protein was
found in two fractions of the gradient. Both peaks were
clearly distinct from the Golgi marker, GDPase and the
ER marker, and cytochrome c reductase. One peak co-
fractionated with the plasma membrane marker Sso1/2p,
consistent with the localization of Sro7p to the plasma
membrane. The second peak was found in the top frac-
tions presumably representing a fraction of the mem-
brane-associated pool that has been stripped of the plasma
membrane because of high sucrose concentration. These
localization data were also confirmed by immunofluores-
cence (Fig. 6 B) on wild-type cells (pB23) or cells contain-
ing high copy SRO7. Like Sec9p, Sro7p is found to localize
to the cytoplasm and all along the plasma membrane.
To determine whether Sro7p is associated with post-
Golgi secretory vesicles, we isolated vesicles accumulated
in either of two late acting sec mutants, sec1-1 (Fig. 7) or
sec6-4 (not shown). Mutants were shifted to 378C for 2 h to
accumulate vesicles, the cells were lysed, and the vesicle-
enriched P3 membrane fraction (Walworth and Novick,
1987) was layered onto a velocity gradient. After centrifu-
gation, the gradients were divided into 16 fractions and
each fraction was assayed for invertase activity and for the
vesicle marker Snc1/2. As expected, both vesicle markers
migrated as a major peak in the center of the gradient but
no detectable peak of Sro7 was found in this region of the
gradient. Instead, the majority of Sro7 in the gradient was
found at the top of the gradient, whereas a smaller fraction
pelleted at the bottom with the plasma membrane markers
(Fig. 7). Identical results were found using vesicles isolated
from a sec6-4 strain, with the profile of Sro7p demonstrat-
ing no Sro7p in the region of the gradient containing the
vesicle peak (not shown). Therefore, like Sec9p, Sro7p
does not associate with post-Golgi secretory vesicles.
Sro7p and Sec9p Are Directly Associated In Vivo
The two-hybrid interaction, post-Golgi secretion defect,
and subcellular localization data strongly suggest that
Sro7p function is likely to involve it binding to Sec9p in
vivo. To test this directly, we examined whether we could
coprecipitate Sec9 and Sro7 proteins after treatment with
the chemical cross-linker, DSP. Yeast strains were gener-
ated that expressed either full-length Sro7p or the COOH-
terminal domain of Sro7p (Fig. 1) behind the GAL1 pro-
moter along with either a myc-tagged Sec9p construct or
an untagged Sec9p as a control. Cells were radiolabeled
with [35S]methionine/cysteine in selective galactose-con-
taining media (to induce the expression of the full-length
or COOH-terminal domain of Sro7p), spheroplasted, and
lysed. Lysates were either treated with the cleavable cross-
linker, DSP, dissolved in DMSO (1DSP) or mock-treated
with DMSO alone (2DSP), boiled in 1% SDS (so that
only covalent associations with myc-Sec9p are retained),
diluted in buffer, and subjected to immunoprecipitation
with the a-myc mAb 9E10. These immunoprecipitates
were boiled in buffer containing 1% SDS/0.1 M DTT to
cleave the cross-linker, and then subjected to immunopre-
cipitation with either a-Sro7p or a-Sec9p antibodies to
monitor the results of the cross-linking. Fig. 8 shows that
full-length Sro7p can be coprecipitated with myc-Sec9p in
a manner that is dependent both on the presence of the
DSP cross-linker and the epitope tag on Sec9p. Interest-
ingly, this interaction was not observed in the strains ex-
Figure 5. Sro7p is found in both cytosolic- and membrane-bound
pools. (A) Affinity-purified antibodies to Sro7p recognize a pro-
tein of z105 kD on SDS-PAGE. Cells from wild-type (SRO7,
SRO77), single disruptants (sro77D or sro7D), double disruptants
(sro77D, sro7D), and strains containing high copy SRO7 (2m
SRO7) were spheroplasted, lysed, and boiled in SDS sample
buffer. The samples were examined by 7% SDS-PAGE gels fol-
lowed by immunoblotting with affinity-purified a-Sro7p antibod-
ies. The higher molecular mass forms present in the SRO7 high
copy lane probably represent denatured aggregates since they
are much less apparent when samples are diluted before boiling
and do not change appreciably during pulse-chase experiments
(data not shown). (B) Sro7p is found in the soluble and mem-
brane fractions of the cell. Cells containing vector only (pB23) or
SRO7 on high copy (pB497) were grown to logarithmic phase,
spheroplasted, lysed, and spun to remove unbroken cells. The ly-
sate was treated with detergent or a mock control and subjected
to two successive centrifugations: 30,000 g for 15 min, and then
the S30 supernatant was centrifuged at 100,000 g for 1 h. Pellet
fractions were resuspended in the same volumes as the superna-
tants to normalize. Samples from each fraction were boiled, ana-
lyzed by 7% SDS-PAGE, and immunoblotted with affinity-puri-
fied a-Sro7p antibody. Samples were also run on a 12.5% gel and
immunoblotted with a-Sso1/2p polyclonal antibody as an internal
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pressing only the COOH-terminal half of the Sro7 protein,
suggesting that whereas this domain is sufficient for bind-
ing in vitro, in vivo the interaction is much more efficient
with the full-length Sro7 protein.
To further investigate the interaction between Sro7p
and Sec9p, we performed immunoprecipitations from
whole cell detergent extracts of wild-type yeast cells ex-
pressing only the endogenous Sro7 and Sec9 proteins (Fig.
9 A). We used saturating amounts of affinity-purified IgG
(or an equivalent amount of preimmune IgG as a control)
directed against either Sro7p or each of the three yeast
post-Golgi SNARE proteins, Sec9p, Sso1/2p, and Snc1/2p.
Fig. 9 B shows that in total yeast extracts, a-Sro7p IgG can
coimmunoprecipitate z6% of Sec9 and 4% of the post-
Golgi SNAREs Sso1/2p and Snc1/2p present in these ly-
sates. Under the same conditions, however, only the Sec9p
immunoprecipitation showed detectable amounts of Sro7p
(0.5%).
Since both Sec9p and Sro7p have significant pools of
protein on both the plasma membrane and in the cytosol,
we examined whether the interaction seen between the
two proteins occurred in one or both pools. For these ex-
periments, it was necessary to use yeast cells expressing
Sec9p on a multicopy plasmid (which results in about a
fivefold increase in Sec9p levels) to readily detect the in-
teraction after the separation of the cytosol and mem-
brane fractions. Lysates were centrifuged at 30,000 g to
separate the soluble and membrane fractions, and then
each was diluted 1:1 with lysis buffer containing 1% NP-40
to solubilize the membranes. The samples were subjected
to immunoprecipitation exactly as for the whole cell ly-
sates. The results, shown in Fig. 10 A, show that Sro7p and
Sec9p can coprecipitate each other in both the membrane
and supernatant fractions of the cell. As expected the
transmembrane SNARE proteins Sso1/2 and Snc1/2 are
predominantly found in association with each other in
the 30,000 g membrane fraction. However, a significant
Figure 6. Sro7p is associated with the plasma membrane in yeast.
(A) Sro7p colocalizes with the plasma membrane marker Sso1/2p
on a sucrose density gradient. Wild-type cells grown to logarith-
mic phase were spheroplasted, lysed, and spun at 30,000 g to pel-
let the membrane-associated pool of Sro7p that was analyzed on
a 20–50% sucrose density gradient. The top shows the fraction-
ation profile of Sro7p and the plasma membrane t-SNARE Sso1/
2p in the gradient as determined by immunoblotting. The bottom
shows the distribution of the GDPase activity (a Golgi marker)
and cytochrome c reductase activity (an ER marker) in the gradi-
ent. Fraction 1 corresponds to the top of the gradient. Sro7p is
found in two pools on the gradient: one that has been released
from the membrane and is found at the top of gradient and a sec-
ond pool that comigrates with the plasma membrane marker
Sso1/2p. (B) Indirect immunofluorescence localization of Sro7p
to the plasma membrane and soluble pool of the cell. Wild-type
cells containing vector only (pB23) or SRO7 on high copy
(pB497) were grown in selective media overnight and shifted in
YPD for 2 h before fixing with formaldehyde. Cells were perme-
abilized using 0.05% SDS and stained with affinity-purified
a-Sro7p antibody and detected using a rhodamine-conjugated
a-rabbit secondary antibody. Stained cells were observed on a
Zeiss LSM 510 confocal microscope and individual Z-slices were
captured with LSM 510 software. Plasma membrane and cytoso-
lic staining is evident in cells containing the high copy SRO7 but
no specific staining was observed in the empty vector control
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amount of association between Sro7p and Sec9p was seen
in both the supernatant and membrane fractions.
Interestingly, as observed for the whole cell immunopre-
cipitates described above, the a-Sro7p antibodies were
found to coimmunoprecipitate significant amounts of the
two other post-Golgi SNARE proteins, Sso1/2p and Snc1/2p,
from the membrane fraction. To determine if this was
likely to be a direct interaction between Sro7p and these
two SNARE proteins or an indirect interaction through
Sec9p, we examined the effect of the preclearing of Sec9
protein on coprecipitation. Immunoprecipitations of the
30,000 g membrane pool were set up as described above,
and then treated with either saturating amounts of a-Sec9p
IgG or an equivalent amount of preimmune IgG. The su-
pernatant of these two immunoprecipitations was sub-
Figure 7. Sro7p is not present on post-Golgi secretory vesicles.
Cells from a BY29 (sec1-1, ura3-52) strain were shifted to 378C in
YP medium with 0.1% glucose for 2 h to accumulate post-Golgi
vesicles and induce expression of invertase. Spheroplasts were
prepared from these cells that were lysed osmotically by gentle
resuspension in lysis buffer containing 0.8 M sorbitol. A 100,000 g
membrane fraction (P3) enriched in post-Golgi vesicles was pre-
pared from a 10,000 g supernatant fraction by differential centrif-
ugation as described previously (Walworth and Novick, 1987).
The P3 vesicle fraction was resuspended in lysis buffer and lay-
ered onto a 20–40% sorbitol velocity gradient as described previ-
ously (Brennwald et al., 1994). The top shows the fractionation
profile of latent invertase (a marker for secretory vesicles) com-
pared with the distribution of total protein in the gradient. Inver-
tase activity is expressed as micromoles of glucose per minute per
fraction. Protein concentrations were determined according to
Bradford (1976). The bottom shows the fractionation of Sro7p
compared with Snc1/2, a marker for post-Golgi vesicles (Proto-
popov et al., 1993). The presence of Sro7p and Snc1/2 in the gra-
dients was determined by immunoblotting followed by quantita-
tion on a STORM PhosphorImager using ImageQuant software.
Similar results were obtained using a P3 fraction prepared from a
sec6-4 strain.
Figure 8. Full-length Sro7p, but not the COOH-terminal half of
Sro7p, can be directly cross-linked to Sec9p in yeast lysates. Co-
precipitation analysis was performed on radiolabeled yeast
strains transformed with either myc-tagged YEpSEC9-myc plas-
mid (pB37) or, as a control, an otherwise identical untagged
YEpSEC9 plasmid (pB37) in strains which contained a construct
overexpressing either full-length Sro7 (pB363) or CT Sro7
(pB367) under control of the inducible GAL1 promoter. All
strains were induced in galactose-containing media for 2 h before
1 h labeling of cells with 35S-Express label in galactose-containing
media. The cells were spheroplasted and lysed osmotically in
PBS. Lysates were immediately subjected to treatment with the
protein cleavable cross-linking agent (DSP) dissolved in DMSO
or a DMSO control for 20 min on ice and subsequently boiled in
1% SDS buffer before dilution with IP buffer. Association be-
cause of cross-linking was monitored by a two-step immunopre-
cipitation protocol with the first immunoprecipitation being with
the a-myc or directly with a-Sro7p antibodies (a-Sro7 IP). After
washing, samples were boiled in 1% SDS/0.1 M DTT (to cleave
the cross-linker), diluted with IP buffer, and subjected to a sec-
ond round of immunoprecipitation with either a-Sro7p (top) or
a-Sec9p (bottom) polyclonal antibodies. Samples were boiled in
sample buffer, resolved by SDS-PAGE, dried, and exposed to
film. The expression from the GAL1-SRO7 and GAL1-SRO7-
CT constructs were similar (compare first and last lanes, marked
a-Sro7 IP). A cross-linker and myc tag–dependent interaction is
apparent between full-length Sro7p and Sec9p, strongly suggest-
ing that these proteins are directly associated with each other in
vivo. In contrast, the COOH-terminal domain does not show a
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jected to precipitation with either a-Sro7p or a-Sec9p IgG
(to monitor the effectiveness of the preclearing), and the
effect on the coprecipitation of Sso1/2p and Snc1/2p was
determined. The results of this experiment, shown in Fig.
10 B, demonstrate the dramatic loss of Sso1/2p and Snc1/2p
coprecipitation by Sro7p when Sec9 protein is removed
from the extracts. This strongly suggests that Sro7p does
not directly associate with these other SNARE proteins
but that it can bind to Sec9p, not only on its own, but also
within the context of a SNARE complex.
SRO7 and SEC9 Suppress Both rho3 and Post-Golgi
sec Mutants
SRO7 was independently isolated as a multicopy sup-
pressor of a mutant in the Rho GTPase, RHO3, which
is thought to play a role in regulating actin polarity of
the yeast cell. rho3 mutants appear to have severe de-
fects in cytoskeletal organization. Specifically, cortical
actin patches, normally present almost exclusively in the bud,
are found randomly distributed throughout the mother
and bud of the rho3 mutant cells (Imai et al., 1996). Rho3
has also been implicated in polarized exocytosis. This ob-
servation stems from the recent identification, by our labo-
ratory, of the RHO3 gene as a high copy suppressor of
sec4-P48, a cold-sensitive Sec4 effector domain mutant.
Furthermore, we have demonstrated that rho3 mutant
cells have a defect in polarity and accumulate post-Golgi
secretory vesicles in the mother cell at the restrictive tem-
perature (Adamo, J., G. Rossi, and P. Brennwald, manu-
script submitted for publication). Genetic interactions in-
volving RHO3 and SEC4 prompted us to determine if
both  SRO7 and SEC9 can act as suppressors of a rho3 de-
letion mutant. Sporulation of a diploid heterozygous for
disruption of the chromosomal RHO3 gene results in a 2:2
segregation pattern for growth at 258C that is linked to the
rho3 disruption. Transformation of the high copy vector,
pRS426, into the heterozygous diploid did not alter this
segregation pattern after sporulation (Fig. 11, top). Ex-
pression of high copy SRO7 strongly suppressed the
growth defect associated with disruption of rho3 (Fig. 11,
middle). SEC9, when expressed on high copy, was even
Figure 9. Sro7p interacts with the post-Golgi SNARE proteins in detergent extracts. (A) Wild-type cells, grown to logarithmic phase
were spheroplasted and lysed in buffer containing 0.5% NP-40. Detergent extracts were subjected to immunoprecipitations with either
saturating amounts (3–10 mg of IgG/1 ml immunoprecipitation) of affinity-purified antibodies against either Snc1/2p, Sso1/2p, Sec9p,
Sro7p, or an equivalent amount of IgG purified from a preimmune bleed of the respective rabbit. After recovery of immune complexes
on protein A–Sepharose beads, beads were washed four times with the same buffer, and then boiled in SDS sample buffer. The samples
were analyzed by SDS-PAGE, and then blotted with a-Sro7p, a-Sec9p, a-Snc1/2p, and a-Sso1/2p antibodies, respectively. To quanti-
tate the samples that contained the same precipitating and immunoblotting antibody, we found it necessary to dilute these samples with
SDS sample buffer before electrophoresis as follows: in the Snc1/2 blot, the Snc1/2 immunoprecipitates (and the control) were diluted
1:4; in the Sso1/2 blot, the Sso1/2 IPs were diluted 1:8; for the Sec9 blot, the Sec9 IPs were diluted 1:2; and for the Sro7 blot, the Sro7 IPs
were diluted 1:2. A fraction of the total detergent lysate was immunoblotted in parallel to determine the total protein present in the im-
munoprecipitation reaction. The efficiency of the immunoprecipitation with saturating amounts of affinity-purified antibodies was cal-
culated as follows: the amount of target protein immunoprecipitated by a given antibody was quantitated after immunoblotting and (af-
ter adjusting for dilution and amount loaded) divided by the amount of protein present in the total sample (after adjusting for the
amount loaded). From this, the efficiency of precipitation by each antibody was determined to be as follows: a-Snc1/2p, 93%; a-Sso1/2p,
63%; a-Sec9p, 76%; and a-Sro7p, 98%. (B) Quantitation of the coimmunoprecipitations. The values are expressed as the amount of
coimmunoprecipitating proteins present as a percentage of the total protein present (see above). 125I–protein A signals on the immuno-
blots were quantitated on a Storm PhosphorImager using ImageQuant software. Note that the numbers that are expressed as a percent-
age of the total protein are higher for Sec9p than for the other three proteins. This is likely due to the fact that the levels of Sec9 protein
found in wild-type yeast are 5–10-fold less than that of Snc1/2p and Sso1/2p, and at least threefold less than Sro7p. Thus, Sec9p is the
limiting factor in these associations.Lehman et al. Yeast Tomosyn Homologues Function in Exocytosis 137
more potent in its suppression of the rho3 deletion (Fig.
11, bottom).
The results suggest that these proteins act together to
promote vesicle transport at the later stages of post-Golgi
transport. While the high copy SRO7 and SEC9 suppress a
number of the late acting sec genes and rho3D, they do not
suppress each other (Table I). High copy SRO7 is unable
to suppress sec9-4 or sec9-7 mutants and high copy SEC9
cannot suppress the sro7/sro77 double disruption, suggest-
ing that although they act at the same stage, they do not
have an identical function. However, they both are strong
suppressors of the sec3, sec8, sec10,  and  sec15 mutants,
suggesting that they function downstream of the exocyst,
in mediating the final steps of vesicle fusion at the plasma
membrane (Table I).
Discussion
In this paper, we describe the identification of Sro7p/
Sro77p as novel components of the yeast exocytotic ma-
chinery. Our initial identification of these genes was based
on their ability to interact with the plasma membrane
SNARE protein Sec9. The biological relevance of this in-
teraction has been supported by a number of observations.
First, the analysis of the cold-sensitive sro7D, sro77D mu-
tants demonstrates a secretion phenotype that is identical
to that of sec9 mutants; that is a block in the docking and
fusion of post-Golgi secretory vesicles with the plasma
membrane. Second, the subcellular localization of Sro7p
resembles that of Sec9p as it is present both in the cytosol
and peripherally associated with the plasma membrane,
and is not found associated with post-Golgi secretory ves-
icles. Third, we have clearly documented its association
with Sec9p both in vitro and in vivo. The in vivo associa-
tion was demonstrated by two methods: first, by chemical
cross-linking and, second, by coprecipitation from deter-
gent extracts. We were also able to show that Sec9p and
Sro7p are found associated both in the cytosol and on the
plasma membrane. Interestingly, we have evidence that
Sro7p is also able to associate with Sec9p when it is
present in SNARE complexes with Sso1/2p and Snc1/2p.
The fact that it associates with Sec9p alone or in the con-
text of the SNARE complex suggests that it likely inter-
acts with a region of Sec9p not directly involved in the
SNARE complex. Recent data from our laboratory sup-
port this idea. Mapping of the two-hybrid interaction be-
tween Sro7p and Sec9p demonstrates that it interacts with
the extreme NH2 terminus of Sec9p, a region important
for the ability of Sec9 to suppress an effector mutant in
Sec4 (Maksimova, M., L. Katz, and P. Brennwald, unpub-
lished data).
Previous work on yeast Sro7/77 and Drosophila lethal
giant larvae function has suggested a role for these pro-
teins in the regulation of the actin/myosin cytoskeleton.
Figure 10. Sro7p interacts specifically with
Sec9p in the cytoplasm and at the plasma mem-
brane. (A) Cells containing high copy SEC9
(pB35) were grown to logarithmic phase, sphero-
plasted, and lysed. The lysate was centrifuged at
30,000 g to separate cytosol and membrane frac-
tions, the samples were adjusted to 0.5% NP-40,
centrifuged at 13,000 g for 10 min to eliminate in-
soluble material, and subjected to coimmunopre-
cipitation analysis as in Fig. 8. Samples were ana-
lyzed by SDS-PAGE and immunoblotted with
a-Sec9p, a-Sro7p, a-Sso1/2p, and a-Snc1/2p anti-
bodies. (B) Serial coprecipitation analysis dem-
onstrates that Sro7p interacts with Sso1/2p and
Snc1/2p only through the interaction with Sec9p.
A 30,000 g membrane fraction was solubilized
with detergent as above and was precleared of
Sec9 protein by immunoprecipitation with satu-
rating amounts of affinity-purified a-Sec9p anti-
body or equivalent amounts of preimmune IgG
as a control. Fractions were subjected to a sec-
ond round of immunoprecipitations with a-Sec9p,
a-Sro7p,  a-Sso1/2p, and a-Snc1/2p polyclonal
antibodies and analyzed as above.The Journal of Cell Biology, Volume 146, 1999 138
This stems from several observations. First, the Dro-
sophila lethal giant larvae gene product has been shown to
be physically associated with nonmuscle myosin II and ap-
pears to cofractionate with the cytoskeleton after deter-
gent extraction (Strand et al., 1994a,b). Second, the yeast
Sro7/77 proteins were initially identified as suppressors of
the Rho3 GTPase, a protein required for normal actin po-
larity (Kagami et al., 1998). The phenotypic analysis of the
sro7D, sro77D mutants by Kagami et al. (1998) appears to
support this notion since defects in actin polarity and in-
tegrity after shifts to the nonpermissive temperature were
observed. Furthermore, they demonstrate physical and ge-
netic interactions between Sro7p and Myo1p, a yeast type
II myosin (Kagami et al., 1998).
The data presented here demonstrate that the primary
function of Sro7/77 is in exocytosis and not in the regula-
tion of the actin cytoskeleton. In the Kagami et al. (1998)
report, the sro7D, sro77D cells were shifted to 198C for 18 h
before staining for actin. In our experiments, we used a
much shorter 3-h shift at 198C for all of our analyses. After
this shorter temperature shift protocol, we found that the
actin cytoskeleton was well organized, with polarized cor-
tical actin patches and cables of normal length. Under
identical temperature shift conditions, we saw a clear and
pronounced defect in Golgi-to-cell surface transport, dem-
onstrating that the exocytic defect is the primary defect as-
sociated with loss of Sro7/77. The actin polarity defect ob-
served by Kagami et al. (1998) is likely to be a secondary
consequence of loss of membrane transport that is neces-
sary for the delivery of the markers of cell polarity to the
cell surface.
Tomosyn, the neuronal homologue of Sro7 and lethal gi-
ant larvae, was initially identified based on its interaction
with syntaxin. At its COOH terminus, tomosyn contains a
domain that is very similar to the helical region of the vesi-
cle SNARE, synaptobrevin/VAMP (Fasshauer et al., 1998;
Masuda et al., 1998). This domain, which contributes one
of the four helices found at the core of the SNARE com-
plex, may serve as a surrogate vesicle SNARE that is used
to occupy or stabilize the other three helices of the
SNARE complex until the real vesicle-bound SNARE is
presented. Interestingly, we find that this domain is absent
in both of the yeast homologues Sro7p and Sro77p, as well
as in all of the other members of the lethal giant larvae
family (Fig. 1 B). Therefore, this domain appears to be a
specialized feature unique to the neuronal homologue.
However, since the ability to interact with SNARE pro-
teins and SNARE complexes does appear to be conserved
in this family of proteins, it is likely that the conserved por-
tions of the protein are also involved in regulating
SNARE function and assembly. Consistent with this no-
tion, Yokoyama et al. (1999) have recently shown that
this domain is necessary but not sufficient for the high af-
finity association with syntaxin. The data presented here
and by Fujita et al. (1998) demonstrate that these proteins
have a conserved role in the regulation of SNARE assem-
bly at the plasma membrane, even though the precise
SNARE protein to which they have the highest affinity in-
teraction appears to be somewhat different in the two sys-
tems.
While it is clear that the Sro7 family of proteins plays an
important role in exocytosis, it is also evident that this is
Figure 11. Suppression of the rho3 deletion by multicopy SRO7
and SEC9. A diploid heterozygous for a disruption of the chro-
mosomal  rho3 gene (a/a,  rho3D::LEU2/RHO3,  leu2-3/leu2-3;
ura3-52/ura3-52) was transformed with multicopy plasmids con-
taining (top) empty vector (pB23), (middle) SRO7 (pB427), or
(bottom) SEC9 (pB35). Tetrads were dissected on YPD plates
and grown for 3 d at 258C.
Table I. Summary of Suppression Properties of High Copy 
SR07 and SEC9
Mutant 2m SRO7 2m SEC9
rho3D 11 111
sro7D, sro77D 111 2
sec4-P48 1 111
sec1-1 21 1
sec2-41 22
sec3-2 11 11
sec4-8 22
sec5-24 22
sec6-4 22
sec8-9 11 11
sec9-4 2 111
sec10-2 12
sec15-1 111 11
Late acting sec and rho3 mutants were transformed with either vector (pRS426),
SRO7 (pB497), or SEC9 (pB35). Transformants grown on selective media were picked
into microtiter plates and tested on YPD plates for growth at four temperatures: 25°,
30°, 34°, and 37°C. Scoring for temperature-sensitive mutants is as follows: triple
plus, wild-type growth at the most restrictive temperature (37°C); double plus, good
growth at an intermediate temperature (34°C) at which empty vector controls cannot
grow; and single plus, slow growth at an intermediate temperature. Scoring for sup-
pression of cold-sensitive mutants was determined by comparing growth relative at
14°C to an isogenic wild-type yeast (111) and to the vector control (2).Lehman et al. Yeast Tomosyn Homologues Function in Exocytosis 139
not an essential function since sro7D, sro77D strains are
able to grow and secrete at levels close to that of wild-type
cells when grown at 378C (Adamo, J., and P. Brennwald,
unpublished data; not shown). Therefore, it appears that
these proteins act in a regulatory role rather than in a
structural role in the process of docking and fusion of post-
Golgi vesicles with the plasma membrane. What is the na-
ture of this regulatory function? The genetic analysis pre-
sented here demonstrates that loss of Sro7/77 function
(i.e., in sro7D, sro77D mutants) has a negative effect on the
exocytic function and that gain of Sro7/77 function (i.e.,
high copy SRO7) has an overall positive effect on exocyto-
sis (seen as suppression of several late acting sec mutants).
Therefore, Sro7/77 act as positive, rather than negative,
regulators of exocytosis.
The suppression of the rho3D mutant by SRO7 and
SEC9 suggests that these three gene products act together
in regulating exocytosis. Recent studies by our laboratory
(Adamo, J., G. Rossi, and P. Brennwald, manuscript sub-
mitted for publication) and others (Imai et al., 1996; Rob-
inson et al., 1999) have suggested that Rho3 plays a direct
role both in regulating the actin cytoskeleton and exocyto-
sis. An attractive model for the function of Sro7/77 in
such a pathway is that it would act to transmit Rho3 func-
tion onto the SNARE complex at the plasma membrane.
Whereas, like Sec9p, Sro7p does not display a polarized
localization on the plasma membrane, it may function in a
polarized fashion in conjunction with an activating signal
from Rho3. The end result of this would be the localized
assembly of Sec9p/Ssop heterodimers in response to the
Rho3-GTP signal. The localized assembly of Q-SNAREs
to specific sites on the plasma membrane would serve to
restrict vesicle docking and fusion to these sites. Since
Rho3 also has a role in regulating actin polarity (Matsui
and Toh, 1992), it may serve to coordinate the dynamic
regulation of the polarity of the actin cytoskeleton with
polarized delivery of membrane and protein to the cell
surface. It is clear that other factors such as the Rab GTP-
ase Sec4 and the exocyst complex play a role in this pro-
cess as well (Finger and Novick, 1997; Guo et al., 1999). It
is worth noting in this regard that Sec9, Sro7, and Rho3
have strong genetic interactions with both Sec4 and multi-
ple subunits of the exocyst complex (Table I; Adamo, J.,
G. Rossi, and P. Brennwald, manuscript submitted for
publication). Unraveling the molecular events by which
these numerous gene products function in this process will
be a major key to understanding how cell polarity is regu-
lated in eukaryotic cells.
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